CNPR Drug Development Process 4

Question 1

Which preclinical requirement must be completed before an IND application can be filed with the FDA?

Accepted Answer

Adequate toxicology and pharmacology studies in animals

Answer

Before filing an IND, sponsors must complete animal toxicology and pharmacology studies sufficient to predict safety for initial human exposure.

Question 2

A drug's 'therapeutic index' (TI) measures the relationship between:

Accepted Answer

The toxic dose and the effective dose — a narrow TI indicates a higher risk drug

Answer

The therapeutic index (TD50/ED50) compares the dose causing toxicity to the dose producing the desired effect; a narrow TI means little margin between effective and harmful doses.

Question 3

What does 'off-label' drug use mean?

Accepted Answer

Prescribing a drug for a use, population, or dose not listed in FDA-approved labeling

Answer

Off-label use is legally permissible for physicians but pharmaceutical reps cannot promote drugs for unapproved indications.

Question 4

Which organization accredits pharmaceutical sales training programs and awards the CNPR certification?

Accepted Answer

The National Association of Pharmaceutical Sales Representatives (NAPSRx)

Answer

NAPSRx (National Association of Pharmaceutical Sales Representatives) administers and awards the CNPR certification for pharmaceutical sales professionals.

Question 5

In the context of clinical trials, 'informed consent' requires that:

Accepted Answer

Participants voluntarily agree to a study after receiving complete information about risks and benefits

Answer

Informed consent is an ethical and legal requirement ensuring participants understand the study's purpose, risks, and their right to withdraw before agreeing to participate.

(CNPR) Certified National Pharmaceutical Representative Practice Test

(CNPR) Certified National Pharmaceutical Representative Practice Test

CNPR Drug Development Process 4